Patrick Radigan 
As new forms of natural medicine make their way into the American political sphere, a decades-old debate rages on about a compound that many believe could be an answer to the country’s current opioid crisis.
Recent moves in the federal government have started to crack the door open to the potential of researching psychedelics for mental health therapy. Now, there’s a race to see who is going to walk through that door first.
Psychedelic access took a bold step forward last week thanks to a decision by the government to end its pursuit of a change in how certain compounds were scheduled.
A bipartisan pact of Senators took the first step in introducing legislation to provide a new treatment path for terminally ill patients.
Psychedelic treatment options found an unlikely vehicle to the floor of congress last week after the House of Representatives voted to look into new ways of helping to stem the problem of mental illness among our nation’s veterans.
Ann Shulgin, a fierce advocate for psychedelics and a groundbreaking researcher, died last weekend at the age of 91.
With election season looming, a surprise ‘entrant’ could be making its way onto the ballot this fall, and into state houses across America: Psychedelics. As a handful of states grapple with psychedelic-related legislation and information gathering, voters in Colorado moved one step closer to voting on legalizing psychedelic mushrooms by